FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/07/2026
Voltar para busca
Dado oficial do USPTO
NORDIC BIOSCIENCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
16/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
19/07/2023
Data de registro
23/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/12/2025
Última transação
16/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
DK
Examinador
BIBB, SCOTT
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of an image of three stylized dots connected with lines, with a single dot to the right, all appearing to the left of the wording NORDIC BIOSCIENCE.
Titulares e representantes
Titulares
Nordic Bioscience A/S
Representantes
Andrew M. Smith Resonate IP, LLC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formationtissue remodelingtissue destruction; diagnostic biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detectiondisease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detectiondisease detectiondisease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use
Classe 42
custom design and development of blood-based biomarker assays to identifyquantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medicalpharmaceuticalscientific purposes; custom design and development of biochemicalpharmaceuticalmedical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formationtissue remodelingtissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific researchidentification of predictive and prognostic biomarkers for clinical trials; medical and scientific researchidentifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysisanalysis of pharmacodynamic data; biological research and analysisanalysis of data relating to biomarkers; development services in the field of diagnostic preparationsequipment and tests; medical and scientific researchconducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; adviceinformation and assistance relating to the foregoing
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/06/2026
FIMP
FINAL DISPOSITION PROCESSED
28/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
23/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/11/2025
PUBO
PUBLISHED FOR OPPOSITION
04/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
07/10/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/10/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/10/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/10/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/11/2024
RFNT
REFUSAL PROCESSED BY IB
03/06/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/05/2024
RFRR
REFUSAL PROCESSED BY MPU
10/05/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/05/2024
CNRT
NON-FINAL ACTION WRITTEN
03/05/2024
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
03/05/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/05/2024
CNRT
NON-FINAL ACTION WRITTEN
02/05/2024
DOCK
ASSIGNED TO EXAMINER
25/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
19/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NORDIC BIOSCIENCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.